Stay updated on Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Sign up to get notified when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page

  1. Check
    3 days ago
    Change Detected
    Summary
    Revision updated to v3.3.4 with added timestamps 2026-01-13 and 2026-01-10 and removed 2026-01-03 and 2026-01-06. No trial content, eligibility criteria, outcomes, or other study data were changed.
    Difference
    0.1%
    Check dated 2026-01-13T17:39:38.000Z thumbnail image
  2. Check
    10 days ago
    Change Detected
    Summary
    New update date entries were added (2026-01-03 and 2026-01-06) and older ones removed (2025-12-26 and 2025-12-29). The core study information remains unchanged.
    Difference
    0.1%
    Check dated 2026-01-06T16:38:38.000Z thumbnail image
  3. Check
    17 days ago
    Change Detected
    Summary
    The study record now shows new update timestamps for 12/29/2025 and 12/26/2025, with earlier timestamps 12/22/2025 and 12/19/2025 removed.
    Difference
    0.1%
    Check dated 2025-12-30T08:46:50.000Z thumbnail image
  4. Check
    24 days ago
    Change Detected
    Summary
    Study location information was updated: new locations across multiple states and Ontario were added, several existing locations were removed, and the page revision now shows v3.3.3.
    Difference
    1%
    Check dated 2025-12-23T08:10:17.000Z thumbnail image
  5. Check
    32 days ago
    Change Detected
    Summary
    The page shows new update timestamps (2025-12-15 and 2025-12-12) and a current 'Last Update Posted' marker, while older timestamps (2025-09-03, 2025-09-02, 2025-06) were removed. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2025-12-16T02:32:17.000Z thumbnail image
  6. Check
    46 days ago
    Change Detected
    Summary
    Revision label updated from v3.3.1 to v3.3.2 on the page footer; no study details or user-facing content were modified. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.0%
    Check dated 2025-12-01T16:37:42.000Z thumbnail image

Stay in the know with updates to Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Tazemetostat + Pembrolizumab in Urothelial Carcinoma Clinical Trial page.